Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflexal V dosing comparison in unprimed children 6 to 35 months
2010-019745-25Phase 3Completed
- Sponsor
- Crucell
- Start
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Inflexal V in influenza (2 arms), sponsored by Crucell. Primary endpoint: Seroprotection rate. Started Jul 2010; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-019745-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019745-25.